In our study, the significant downregulation of PON1 in DN patients may indicate impaired antioxidant defense in the kidney, contributing to enhanced oxidative damage, endothelial dysfunction, and progression of glomerular injury. This evidence concerns the gene PON1 and liver dysplastic nodule.